{
    "nct_id": "NCT05048082",
    "official_title": "A Phase 2, Single-Dose, Open-Label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies, in Patients Undergoing Routine Surgery",
    "inclusion_criteria": "* Biopsy confirmed diagnosis, or a high clinical suspicion of a lung malignancy based on MRI, CT and/or PET imaging\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Known hypersensitivity or allergy to indocyanine green (ICG), polymethylmethacrylate (PMMA; found in dental and bone cements) or polyethylene glycol (PEG)\n* Tumor locations the surgeon deems unfeasible to image intraoperatively\n* Excessive and/or generalized disease deemed inoperable by the surgeon\n* Life expectancy less than 12 weeks",
    "miscellaneous_criteria": ""
}